HSPB8 and breast cancer: Instead, the SERM tamoxifen had no effects on HSPB8 [25], but HSPB8 is highly overexpressed in tamoxifen-resistant BC (MCF-7) cell subclones [28], possibly favouring appearance of drug-resistance in cancer cells [28, 29].